FCM
CME icon

Fourpath Capital Management’s CME Group CME Stock Holding History

Fourpath Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Buy
19,578
+413
+2% +$114K 0.57% 46
2026
Q1 		$5.66M Buy
19,165
+1,202
+7% +$357K 0.81% 30
2025
Q4 		$4.91M Buy
17,963
+2,366
+15% +$643K 0.67% 37
2025
Q3 		$4.21M Sell
15,597
-75
-0.5% -$20.4K 0.6% 46
2025
Q2 		$4.32M Sell
15,672
-196
-1% -$53.3K 0.68% 39
2025
Q1 		$4.21M Sell
15,868
-75
-0.5% -$18.5K 0.73% 39
2024
Q4 		$3.7M Sell
15,943
-453
-3% -$104K 0.69% 44
2024
Q3 		$3.62M Buy
+16,396
New +$3.39M 0.67% 46

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Fourpath Capital Management's CME Position: Q2 2026 in Review

Fourpath Capital Management increased its CME Group (CME) stake by 2.2% in Q2 2026, buying an estimated $114K and bringing the position to 19,578 shares worth $4.32M. The position accounts for 0.57% of the portfolio, ranked #46.

Fourpath Capital Management first reported a position in CME in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.66M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Fourpath Capital Management held 19,578 shares of CME Group worth $4.32M as of Q2 2026.
  • Fourpath Capital Management bought 413 CME Group shares in Q2 2026, an estimated $114K.
  • CME Group made up 0.57% of Fourpath Capital Management's portfolio in Q2 2026, its #46 holding.
  • Fourpath Capital Management first reported a position in CME Group in Q3 2024 and has held it in 8 quarters since.
  • Fourpath Capital Management's CME Group position peaked at $5.66M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.